Circulating Biomarkers for Predicting Infliximab Response in Rheumatoid Arthritis: A Systematic Bioinformatics Analysis

BACKGROUND: Infliximab shows good efficacy in treating refractory rheumatoid arthritis (RA). However, many patients responded poorly and related studies were inconsistent in predictive biomarkers. This study aimed to identify circulating biomarkers for predicting infliximab response in RA. MATERIAL/...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Qiu-lan, Zhou, Fu-jiang, Wu, Cheng-bin, Xu, Chao, Qian, Wen-ying, Fan, De-ping, Cai, Xu-shan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2017
Materias:
Lab/In Vitro Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5404751/
https://www.ncbi.nlm.nih.gov/pubmed/28413214
http://dx.doi.org/10.12659/MSM.900897

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5404751/
https://www.ncbi.nlm.nih.gov/pubmed/28413214
http://dx.doi.org/10.12659/MSM.900897

Ejemplares similares